115
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

One-pot reactions in the synthesis of thiazolidinone derivatives by nano-Fe3O4–cysteine catalyst

, , ORCID Icon &
Pages 655-670 | Received 07 Mar 2022, Accepted 30 May 2022, Published online: 24 Jun 2022
 

Abstract

A simple and efficient one-pot approach for assembling some benzylidene-2-(benzo[d]thiazol-2-ylimino) thiazolidin-4-one derivatives utilizing Fe3O4–cysteine as an efficient catalyst via reaction between benzo[d]thiazol-2-amine, ammonium thiocyanate, chloroacetyl chloride, and aromatic aldehydes, in EtOH at 80°C, is reported. Minimize chemical waste, time-saving, simplify practical aspects besides the good functional group tolerance and easy separation of the nano-catalyst are the prominent features of the present methodology. In vitro antibacterial screening of synthesized compounds against Staphylococcus aureus ATCC 25923, Staphylococcus epidermidis ATCC 1446, Bacillus cereus ATCC 1247, Escherichia coli ATCC 1399, and Pseudomonas aeruginosa ATCC 1430 in different concentrations of the samples (200, 100, 50, 25, 12.5, 5.25, and 3.12 µg/ml) was done, and the lowest minimum inhibitory concentration, minimum bactericidal concentration, the zone inhibitory were measured, and biofilm formation was investigated.

GRAPHICAL ABSTRACT

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

We gratefully acknowledge the financial support from the Research Council of Tehran North Branch, Islamic Azad University.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.